Your browser doesn't support javascript.
loading
Application of the adverse outcome pathway framework to genotoxic modes of action.
Sasaki, Jennifer C; Allemang, Ashley; Bryce, Steven M; Custer, Laura; Dearfield, Kerry L; Dietz, Yasmin; Elhajouji, Azeddine; Escobar, Patricia A; Fornace, Albert J; Froetschl, Roland; Galloway, Sheila; Hemmann, Ulrike; Hendriks, Giel; Li, Heng-Hong; Luijten, Mirjam; Ouedraogo, Gladys; Peel, Lauren; Pfuhler, Stefan; Roberts, Daniel J; Thybaud, Véronique; van Benthem, Jan; Yauk, Carole L; Schuler, Maik.
Afiliação
  • Sasaki JC; Genentech, Inc., South San Francisco, California.
  • Allemang A; Procter & Gamble, Mason, Ohio.
  • Bryce SM; Litron Laboratories, Rochester, New York.
  • Custer L; Bristol-Myers Squibb Company, Drug Safety Evaluation, New Brunswick, New Jersey.
  • Dearfield KL; Burke, Virginia.
  • Dietz Y; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.
  • Elhajouji A; Novartis Pharma AG, Basel, Switzerland.
  • Escobar PA; Merck &Co. Inc., West Point, Pennsylvania.
  • Fornace AJ; Georgetown University, Washington, District of Columbia.
  • Froetschl R; Federal Institute for Drugs and Medical Devices, Bonn, Germany.
  • Galloway S; Merck &Co. Inc., West Point, Pennsylvania.
  • Hemmann U; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.
  • Hendriks G; Toxys, Leiden, The Netherlands.
  • Li HH; Georgetown University, Washington, District of Columbia.
  • Luijten M; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • Ouedraogo G; L'oréal Recherche & Innovation, Aulnay-Sous-Bois, France.
  • Peel L; Health and Environmental Sciences Institute, Washington, District of Columbia.
  • Pfuhler S; Procter & Gamble, Mason, Ohio.
  • Roberts DJ; Charles River Laboratoires, Skokie, Illinois.
  • Thybaud V; Sanofi, Research and Development, Preclinical Safety, Vitry-sur-Seine, France.
  • van Benthem J; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • Yauk CL; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada.
  • Schuler M; Pfizer Inc, World Wide Research and Development, Groton, Connecticut.
Environ Mol Mutagen ; 61(1): 114-134, 2020 01.
Article em En | MEDLINE | ID: mdl-31603995
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rotas de Resultados Adversos / Testes de Mutagenicidade / Mutagênicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rotas de Resultados Adversos / Testes de Mutagenicidade / Mutagênicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article